In an evaluable cohort of 5570 NSCLC patients, concurrent RNA-NGS and DNA-NGS detected 18.6% more patients harboring MET exon 14 skipping alterations compared with DNA-NGS alone [91]. Here, MET is linked to non-small cell lung carcinoma.